Clin2
NCT07769255Possibly a fitRecruiting

Nebulized dexmedetomidine for early chronic migraine

Chronic Migraine

Treatments studied

This trial tests whether a medicine called dexmedetomidine, given through a nebulizer (mist you breathe in), can help reduce the number of headache days and prevent migraines from becoming chronic. It is for people who have recently started having many headache days each month.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
146 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You have had migraine with 15 or more headache days per month for less than 6 months.
  • You have not taken any migraine prevention medication in the last 8 weeks.
  • You do not have heart, lung, psychiatric, or other neurological conditions.
  • You are not currently taking sedatives, opioids, or CGRP-targeting therapies.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07018713Recruiting· Phase 3
Testing Xeomin injections to prevent chronic migraine

This trial tests if Xeomin (a botulinum toxin injection) can help prevent chronic migraine. If you have frequent migraine headaches, you may be able to join.

Chandler, Arizona
NCT06641206Recruiting
Dexmedetomidine injection for chronic knee pain

This trial tests whether a single injection of dexmedetomidine into the knee joint can reduce chronic knee pain. It is for people who are not scheduled for knee surgery and have no serious health problems.

Tanta, El Gharbyia
NCT07522736Recruiting
Spinal anesthesia with dexmedetomidine for knee surgery

This trial tests adding dexmedetomidine (a calming medication) to bupivacaine (numbing medication) injected into the spine during knee surgery. The goal is to improve pain relief and recovery after surgery.

Cairo
NCT07493785Not yet recruiting· Phase 2/Phase 3
Dexmedetomidine for premature babies on a breathing machine

This trial tests a medication called dexmedetomidine to help keep premature babies calm and comfortable while on a breathing machine. It may reduce the need for stronger sedatives and improve recovery.

Brest
NCT06935552Not yet recruiting· Early Phase 1
Ketamine and lidocaine infusion for severe chronic migraine

This trial tests if a combination of ketamine and lidocaine given through an IV can help people with constant, hard-to-treat migraines. It aims to find a new relief option for those who haven't improved with other treatments.

NCT07480304Enrolling by invitation
Dexmedetomidine mist for stable breathing tube placement

This trial tests if a medication called dexmedetomidine (given as a mist through a nebulizer) can help keep your heart rate and blood pressure steady when a breathing tube is placed for surgery. It may be an option for people having planned surgery who want a smoother experience.

Karachi, Sindh

Hear when a new Chronic Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.